Fakultas

Road Map

This roadmap is designed as a strategic guideline for the development of the Pathobiology specialization, oriented toward the advancement of scientific knowledge, research innovation, and contributions to the understanding of disease mechanisms at the molecular and cellular levels. The formulation of this roadmap takes into account recent scientific developments, the need to translate research findings into clinical practice, as well as opportunities for national and international collaboration.

Five-Year Development Roadmap

No.
 Year of Activity
 Activity Plan
Outcome
1 2025 – 2026

1. Identification of supporting facilities

2.  Developing a Collaboration & Networking plan with research group partners from national and international institutions to formulate impactful research topics

3. Preparation of a Proposal with the topic:

3.a. Evaluating the potential of natural materials as candidate anticancer agents as well as adjuvant agents to reduce chemotherapy side effects through in vitro and in vivo studies in experimental animal models

    3.b. Pathomechanisms of cellular signaling pathways involved in growth, invasion, metastasis, and prognosis.

3.c. Mechanisms of tumor microenvironment interactions (immune cells, stroma, angiogenesis) in cancer development.

4. FGD for proposal development, association formation, website creation, and publication of scientific journals in the field of Pathobiology

 

  1. 5-year research roadmap/blueprint document
  2. List of supporting facilities
  3. FGD result documents
  4. Website of Indonesian Cancer Pathobiology Group
  5. Research Proposal

 
2  2027 – 2028

Implementation of research that has been planned for the previous year

Monev
  • Research progress report
  • Report on the implementation of collaboration
3 2027 – 2028 Implementation of 2nd year research and analysis of research results  
4 2028 – 2029 Result Dissemination
  • International publications in journals indexed by Scopus or included in international databases
  • Intellectual Property Rights (IPR)